Functional analysis of spoT, relA and dksA genes on quinolone tolerance in Pseudomonas aeruginosa under nongrowing condition

Microbiology and Immunology
Darija ViducicYoichiro Miyake

Abstract

To assess the contribution of ppGpp in antibiotic tolerance to quinolone in Pseudomonas aeruginosa, knockout mutants of the genes involved or linked with the stringent response, such as relA, spoT and dksA, were constructed and investigated for their antibiotic susceptibility to quinolones. The survival of the dksA and spoT mutants in the presence of 8 microg/ml of ofloxacin and 1 microg/ml of ciprofloxacin were shown to be approximately 20-180 and 10-40 times respectively, higher than the same for the wild type strain. The intracellular levels of ppGpp determined with high performance liquid chromatography (HPLC) demonstrated that spoT and dksA mutants possess higher basal levels of ppGpp. The data suggest that elevated basal levels of ppGpp may be responsible for rendering these mutants tolerant to quinolones and expand the importance of ppGpp as an antimicrobial target in P. aeruginosa.

References

Dec 25, 1989·Nucleic Acids Research·A W Smith, B H Iglewski
May 31, 1996·Journal of Molecular Biology·K D Murray, H Bremer
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·E AizenmanG Glaser
Apr 19, 2000·Antimicrobial Agents and Chemotherapy·J C Fung-TomcD P Bonner
Jan 16, 2002·Journal of Bacteriology·Clare M TaylorIan S Roberts
Jul 27, 2002·Journal of Bacteriology·Larissa BrownMichael Cashel
Sep 13, 2002·Canadian Journal of Microbiology·Grant J Balzer, Robert J C McLean
May 31, 2003·Journal of Bacteriology·Florence JudeChristian van Delden
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Kazuko TaniguchiYoichiro Miyake
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kosaku TakahashiKozo Ochi
Jun 10, 2004·Molecular Microbiology·Javier Pizarro-Cerdá, Karsten Tedin
Dec 29, 2004·FEMS Microbiology Letters·Keiji MurakamiYoichiro Miyake
May 4, 2005·Trends in Microbiology·Lisa U MagnussonThomas Nyström
May 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Brian J PaulRichard L Gourse

❮ Previous
Next ❯

Citations

Aug 2, 2007·Journal of Applied Genetics·Agnieszka Szalewska-PalaszAlicja Wegrzyn
May 24, 2012·The Journal of Antimicrobial Chemotherapy·Keith Poole
Jan 31, 2007·Antimicrobial Agents and Chemotherapy·Darija ViducicYoichiro Miyake
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Jerrylynn ManuelTeresa de Kievit
May 29, 2010·Microbiology and Molecular Biology Reviews : MMBR·Zachary D DalebrouxMichele S Swanson
Feb 4, 2014·PloS One·Mariangela TaboneJuan C Alonso
Jun 13, 2012·Nihon saikingaku zasshi. Japanese journal of bacteriology·Tsuneko OnoYoichiro Miyake
Apr 1, 2011·Environmental Microbiology·Sophie de Bentzmann, Patrick Plésiat
Aug 26, 2011·British Journal of Pharmacology·Geraint B RogersKenneth D Bruce
May 1, 2010·Journal of Cellular Physiology·Jun WuJianping Xie
Jan 25, 2011·Molecular Microbiology·Crysten E Blaby-HaasValérie de Crécy-Lagard
May 26, 2010·FEMS Immunology and Medical Microbiology·Morten HarmsenTim Tolker-Nielsen
Jun 11, 2009·FEMS Microbiology Letters·Valerie N De GrooteJan Michiels
Aug 4, 2009·FEMS Microbiology Letters·Shizuo KayamaYoichiro Miyake
Dec 17, 2016·Science·Alexander HarmsKenn Gerdes
Mar 24, 2017·FEMS Microbiology Reviews·Bram Van den BerghJan Michiels
Mar 10, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Keiji MurakamiYoichiro Miyake
Sep 21, 2018·PloS One·Shawn LewenzaShauna Reckseidler-Zenteno
Jul 20, 2016·Antimicrobial Agents and Chemotherapy·Darija ViducicYoichiro Miyake
Apr 26, 2017·Antimicrobial Agents and Chemotherapy·Keiji MurakamiYoichiro Miyake
Sep 4, 2014·Microbiology and Molecular Biology Reviews : MMBR·David LebeauxChristophe Beloin
Mar 7, 2017·Frontiers in Cellular and Infection Microbiology·M Fata MoradaliBernd H A Rehm
Apr 30, 2016·The Journal of Biological Chemistry·Heleen Van Acker, Tom Coenye
May 17, 2017·The Journal of Antimicrobial Chemotherapy·Takashi AmohYoichiro Miyake
May 30, 2017·Frontiers in Microbiology·Darija ViducicYoichiro Miyake
Oct 31, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Negar NarimisaFaramarz Masjedian Jazi
Jul 29, 2020·Antimicrobial Agents and Chemotherapy·Olga PaciosMaria Tomás
Dec 31, 2020·Antibiotics·Cristina UruénJesús Arenas
May 1, 2021·Microbial Pathogenesis·Igor V Chebotar'Vladimir M Mikhailovich
Jun 25, 2015·Microbiology Spectrum·Bree B AldridgeSarah M Fortune

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.